Researchers isolate cells that weaken immune response to cancer February 17, 2017By Rachael Zimlich RNStudy provides new insight on isolating and suppressing immune cells that could play a vital role in inhibiting other immunotherapy efforts against cancer. Study: Safety, components concerns spur vaccine hesitancy February 17, 2017By Rachael Zimlich RNResearchers find callers to a national health center were most concerned about the safety and components of vaccines based largely on old information. As Arkansas outbreak ends, third MMR dose debate renewed January 25, 2017By Rachael Zimlich RNThe prevalence of mumps in the state is reinvigorating the question about whether a third dose of measles, mumps and rubella vaccination is warranted. Study: Saliva test shows promise in checking immunity status January 25, 2017By Rachael Zimlich RNSaliva-based testing may be just as effective as serum in assessing antibodies against infections like community-acquired pneumonia, according to a new UK study. Unvaccinated adults cost U.S. billions in care, lost productivity December 13, 2016By Rachael Zimlich RNLead researcher hopes results of new study motivates more adults to improve vaccination compliance. Duke launches campaign to boost adult vaccination December 13, 2016By Rachael Zimlich RNResearchers and physicians are working together to discover why adults skip recommended vaccines and what doctors can do to increase immunization rates. Alzheimer’s vaccine targets early and later disease stages November 10, 2016By Rachael Zimlich RNA new vaccine against Alzheimer’s targets two proteins involved in the development of the disease in hopes to offer both early and late protection. Researchers zero in on a cure for the common cold November 10, 2016By Rachael Zimlich RNScientists at Emory University have developed a vaccine they say may work well in preventing infection with rhinovirus—the top cause of the common cold. CDC announces 2016-17 flu vaccine changes October 11, 2016By Rachael Zimlich RNThe CDC reaffirms its decision to pull the intranasal vaccine, but allow vaccination in egg-allergic individuals. Coding, careful planning can reduce vaccine-associated losses October 11, 2016By Rachael Zimlich RNPractices that scrutinize vaccine costs and plan ahead may not make much off of vaccinations, but could cut some of their losses.